.Novo Nordisk is continuing its press in to hereditary medicines, accepting pay NanoVation Therapeut...
.Innovent Biologics has produced the scenario that its own gate inhibitor-cytokine fusion protein ha...
.A phase 3 test of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (A...
.Five months after Rakovina Therapies rotated towards expert system, the cancer-focused biotech has ...
.Ascendis Pharma has become a potential hazard to BioMarin's Voxzogo, stating stage 3 development di...
.Though Alkeus Pharmaceuticals' dental eye illness asset stopped working to considerably minimize ge...
.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually quick and easy to miss...
.Invulnerable checkpoint inhibitors are the superheroes of cancer treatment. Medications like Bristo...
.Accept to this week's Chutes & Ladders, our roundup of notable management hirings, shootings and...
.Regeneron is back with long-lasting consequence for its LAG-3 inhibitor as well as PD-1 prevention ...